Bio-Geometry is an open source machine learning platform provider for macromolecular drug research and development, dedicated to developing next-generation artificial intelligence technologies such as geometric deep learning and deep generative models for macromolecule drug research and development. Recently, Biogeo has completed an angel round of financing of tens of millions of dollars, and the investor is Gaorong Capital. The team also released TorchProtein, the first open-source machine learning platform for macromolecular drug research and development, dedicated to accelerating the process of drug research and development through AI.
This article is reproduced from: https://www.itjuzi.com/investevent/13556911
This site is for inclusion only, and the copyright belongs to the original author.